Last reviewed · How we verify
conventional interferon alfa
At a glance
| Generic name | conventional interferon alfa |
|---|---|
| Also known as | Inj uniferon 3 Million International Units |
| Sponsor | Services Institute of Medical Sciences, Pakistan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
- Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis (NA)
- Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
- Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection (NA)
- Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients (PHASE4)
- Advanced Cervical Cancer Trial in India (PHASE2)
- Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer (PHASE2)
- The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: